Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (AIRDF) announced the launch of Rocket Doctor’s digital health platform and marketplace in Florida, expanding its U.S. footprint. More than a dozen Florida-licensed physicians are already onboarded and ready to care for patients. The launch follows operations in California, New York and Maryland, where approximately 24 million covered lives already have in-network access to board-certified physicians using the platform.
The Florida platform provides physicians with digital health software, billing infrastructure and clinical workflow tools to launch and manage independent virtual or hybrid care practices. The company aims to expand access to primary and urgent care across urban, rural and underserved communities while strengthening its digital healthcare infrastructure in the state.
Rocket Doctor AI (AIRDF) announced its subsidiary Rocket Doctor was named a finalist in the 8th Annual Digital Health & AI Awards.
The wholly owned subsidiary is one of five finalists in the Best in Class track for Civic Health: Affordability, Access & Health Equity, selected from over 1,800 submissions worldwide. The awards are hosted by the Digital Health Hub Foundation at HLTH 2026 in Las Vegas.
Rocket Doctor will also present a pitch in the Innovations from Canada showcase on November 16, 2026, and be featured in its pavilion. The awards grand finale takes place that same day at HLTH.
Rocket Doctor AI (AIRDF) completed 53,348 patient visits across the U.S. and Canada in the third quarter of 2026. U.S. visits increased 56% quarter-over-quarter to 6,101 from 3,911, while Canadian visits rose 24% year-over-year to 47,247 from 37,960. U.S. clinical hours increased 33% to 2,634 from 1,987.5 in Q2 2026.
The company expects record Q3 2026 revenue as cash collections catch up with patient activity. Certain U.S. revenues are recognized on a cash basis, creating a lag between visits and revenue recognition. Reimbursement for out-of-network visits is generally not expected, and any recoveries are recognized only upon cash receipt. The U.S. network includes more than 20 in-network payer agreements covering commercial insurance, Medicare Advantage and Medicaid. Management plans to continue evaluating coverage and payer relationships to convert out-of-network patients and physicians to in-network status.
Rocket Doctor AI (AIRDF) will participate in the CANTech Letter Investment Conference in Toronto on October 8, 2026. Dr. William Cherniak, founder and CEO of Rocket Doctor, will present from 4:00–4:30 PM Eastern Time in Track 2. The presentation will cover Rocket Doctor AI’s platform, solutions, recent milestones and growth strategy.
Rocket Doctor AI (AIRDF) will present at the National Investment Banking Association’s 153rd Investment Conference on October 7, 2026. CEO Dr. Essam Hamza will deliver the presentation live in Fort Lauderdale, Florida, covering the company’s platform, recent milestones and growth strategy.
Rocket Doctor AI (AIRDF) issued an interim operational update on U.S. performance for July–August 2026 ahead of its September 14 global Town Hall.
Completed U.S. patient visits reached 3,625 for the two months ended August 31, 2026, equal to 93% of the 3,911 completed visits in the entire Q2 2026 three‑month period. U.S. clinical hours increased to 1,555 hours over the same two‑month period, reaching 78% of the 1,987.5 clinical hours recorded in Q2 2026.
The company reiterates that certain U.S. revenues are recognized on a cash basis, creating a timing lag between rising visit volumes and reported revenue. Rocket Doctor AI distinguishes between in‑network and out‑of‑network U.S. patients, allows out‑of‑network access to drive adoption, submits out‑of‑network claims where possible, and will only recognize any related revenue upon cash receipt due to collection uncertainty.
Rocket Doctor AI (AIRDF) will host a virtual Company Town Hall on Monday, September 14, 2026, to review Q2 2026 milestones and outline its growth strategy for the United States and Canada for the remainder of 2026.
The event will be co-led by CEO Dr. Essam Hamza of Rocket Doctor AI and Founder and CEO Dr. William Cherniak of Rocket Doctor Inc. The town hall, held via Zoom at 1300 Pacific / 1600 Eastern, is open to team members, key stakeholders, investors and strategic partners.
Rocket Doctor AI delivers physician-built, AI-powered healthcare solutions, including its Global Library of Medicine decision support system and a digital health platform that has supported over 350 MDs in more than 750,000 patient visits.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) reported Q2 2026 revenue of $734,028, up 43% year over year from $512,756 and broadly in line with Q1 2026’s $737,103. Net loss widened to $6.67 million, or $0.07 per share, with Adjusted EBITDA loss at $4.12 million.
Gross margin declined to 65% from 75% in Q1 2026 and 89% in Q2 2025, reflecting a changing revenue mix as U.S. operations scale. U.S. completed patient visits rose to 3,911, a 196% increase from 1,319 in Q1, while total U.S. in-network reach expanded to about 24 million covered lives across California, New York, and Maryland.
Canada remained a core market with completed visits rising 23% year over year to 45,766. As of June 30, 2026, cash and equivalents were $0.95 million, up from $0.64 million at December 31, 2025. Subsequent to quarter-end, the company raised roughly CAD$3.26 million via oversubscribed unsecured convertible debentures, secured additional NIH funding exceeding US$500,000 in total, achieved SOC 2 Type 1 compliance, expanded multiple U.S. payer and network agreements, and appointed a new Chief Financial Officer.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF, Frankfurt:939) announced that doctors using its subsidiary Rocket Doctor Inc.’s digital health platform have entered a strategic provider network agreement with a leading national technology-enabled network partner in California, effective July 1, 2026, with an initial one‑year term and automatic annual renewals.
The agreement grants participation across five network channels—Primary, Complementary, Workers’ Compensation, Auto Medical and Medicare Advantage—providing access to upstream insurers, employer health plans and other organizations, subject to participation and eligibility requirements. The national network serves more than 700 health plans, over 100,000 employers, about 60 million consumers and approximately 1.4 million providers, giving Rocket Doctor a single contracted pathway into multiple U.S. healthcare and reimbursement channels, including California’s telehealth-supported workers’ compensation and auto medical markets.
Rocket Doctor AI (OTC:AIRDF) announced that physicians using its subsidiary Rocket Doctor’s digital health platform have entered into an agreement with a major national insurer to expand in-network, physician-led virtual care for eligible Medicare Advantage PPO and commercial plan members in New York.
The deal adds access for more than 100,000 eligible covered lives in the New York City metro area and select upstate counties, plus eligible out-of-state members via a reciprocal network program. Rocket Doctor now reaches about 10 million covered lives in New York and 24 million across the U.S. The agreement, signed July 15, 2026, has an initial one-year term with automatic yearly renewals.